Quince Therapeutics Inc. (QNCX)
NASDAQ: QNCX
· Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.62
-4.71%
After-hours: Aug 15, 2025, 07:43 PM EDT
Quince Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -9.44M | -15.03M | -12.46M | -5.49M | -27.73M | -11.15M | -8.89M | -5.35M | -4.89M | -12.25M | -5.53M | -7.92M | -16.56M | -21.64M | -23.4M | -21.71M | -21.75M | -23.09M |
Depreciation & Amortization | 29K | 32K | 16K | 86K | 44K | 40K | 304K | n/a | 1K | 17K | 42K | 40K | 84K | 38K | 84K | 87K | 87K | 86K |
Stock-Based Compensation | -6.58M | 1.39M | 1.13M | 1.12M | 1.22M | 1.27M | 1.09M | 1.33M | 1.32M | 1.48M | 1.63M | 694K | 5.05M | 9.24M | 8.49M | 7.62M | 6.75M | 6.99M |
Other Working Capital | 2.68M | 2.03M | 544K | 673K | -1.76M | -864K | 377K | -134K | 1.5M | 524K | -1.15M | 384K | -434K | -2.68M | -1.83M | 723K | -7.33M | 2.81M |
Other Non-Cash Items | 7.2M | 1.96M | 1.87M | -5.21M | 19.14M | 2.29M | 3M | -719K | -1.32M | 5.83M | -208K | 1.05M | 215K | 135K | 66.75M | 11K | 96K | 92K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.82M | n/a | 856K | -248K | n/a | -284K | -284K | n/a | -66.55M | 237K | 240K | 202K |
Change in Working Capital | 3.86M | 2.05M | 1.9M | 2.23M | -1.42M | -805K | 250K | -79K | 201K | 1.6M | -1.77M | -281K | -3.92M | -3.86M | 205K | -3.59M | -2.98M | 2.1M |
Operating Cash Flow | -4.92M | -9.6M | -7.55M | -7.26M | -8.74M | -8.35M | -6.08M | -4.82M | -3.83M | -3.57M | -5.83M | -6.7M | -15.41M | -16.09M | -14.42M | -17.34M | -17.56M | -13.61M |
Capital Expenditures | -269K | -148K | -133K | -46K | -39K | -39K | -24K | n/a | n/a | -136K | -78K | -50K | -10.63M | -5K | -44K | n/a | -99K | -37K |
Cash Acquisitions | -135K | n/a | n/a | n/a | n/a | n/a | -2.12M | n/a | n/a | 90K | 10.43M | 35K | 10.63M | 135K | 878K | n/a | n/a | 202K |
Purchase of Investments | -4.83M | -1.95M | n/a | -3.84M | -46.43M | -39.29M | -18.66M | -44.98M | -42.44M | -7.69M | -8.25M | -29.92M | -27.89M | -8.96M | -3.01M | -10.61M | -13.19M | -11.98M |
Sales Maturities Of Investments | 8.04M | 12.64M | 10.51M | 9.13M | 41.49M | 48.24M | 26.7M | 49.12M | 22.12M | 13.28M | 27M | 21.11M | 12.01M | 22.38M | 23.97M | 11.38M | 18.91M | 43.66M |
Other Investing Acitivies | 725K | 355K | 490K | 1.86M | n/a | n/a | -500K | -500K | -20.32K | 5.68K | -10.43M | 35K | 10.63M | -135K | -878K | 766K | 5.72M | -202K |
Investing Cash Flow | 3.52M | 10.9M | 10.87M | 7.11M | -4.98M | 8.91M | 5.39M | 3.63M | -20.32M | 5.54M | 18.67M | -8.83M | -5.25M | 13.41M | 20.92M | 766K | 5.62M | 31.64M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -6K | n/a | n/a | -6K | -18K | -19K | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.5M | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13.88M | n/a | n/a | -5M | n/a | n/a | 6K | n/a | 26K | 56K | n/a | 14K | 108K | 14K | 990K | 4.71M | 672K | 441K |
Financial Cash Flow | 13.88M | 87K | n/a | -5M | 35K | 190K | 57K | 10K | 26K | 50K | -18K | -5K | 108K | 622K | 990K | 4.71M | 672K | 441K |
Net Cash Flow | -50.74M | 1.56M | 3.54M | -5.21M | -13.92M | 1.06M | -880K | -1.02M | -24.06M | 2.13M | 12.77M | -15.12M | -20.64M | -2.16M | 7.52M | -11.84M | -11.27M | 18.47M |
Free Cash Flow | -5.19M | -9.75M | -7.68M | -7.31M | -8.78M | -8.39M | -6.1M | -4.82M | -3.83M | -3.71M | -5.91M | -6.75M | -26.04M | -16.1M | -14.46M | -17.34M | -17.66M | -13.65M |